Safety of pre-procedure fasting versus non-fasting protocols before cardiac catheterization - a Bayesian meta-analysis of randomized clinical trials.

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Abhishek Chaturvedi, Abdullah K Al Qaraghuli, Beni R Verma, Dan Haberman, Matteo Cellamare, Cheng Zhang, Jason Galo, Waiel Abusnina, Lior Lupu, Hayder D Hashim, Toby Rogers, Itsik Ben-Dor, Lowell F Satler, Ron Waksman
{"title":"Safety of pre-procedure fasting versus non-fasting protocols before cardiac catheterization - a Bayesian meta-analysis of randomized clinical trials.","authors":"Abhishek Chaturvedi, Abdullah K Al Qaraghuli, Beni R Verma, Dan Haberman, Matteo Cellamare, Cheng Zhang, Jason Galo, Waiel Abusnina, Lior Lupu, Hayder D Hashim, Toby Rogers, Itsik Ben-Dor, Lowell F Satler, Ron Waksman","doi":"10.1016/j.carrev.2025.08.019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fasting prior to cardiac catheterization is a routine practice to minimize the risk of complications. Recent studies suggest that non-fasting protocols may be equally safe and increase patient satisfaction. We performed a meta-analysis of randomized controlled trials (RCTs) to examine the safety of fasting versus non-fasting prior to cardiac catheterization.</p><p><strong>Methods: </strong>We searched for eligible RCTs comparing fasting versus non-fasting protocols prior to cardiac catheterization from inception through December 21, 2024. Studies were included if they reported at least one of the outcomes of interest- nausea/vomiting, aspiration event, new ventilation/oxygen requirements, hypotension, hypoglycemia, and acute kidney injury. The treatment effect of each outcome was measured using the logarithmic odds ratios (logOR) and estimated under the Bayesian paradigm. Under the hierarchical Bayesian random effect model, we elicited an informative prior for the logOR ∼ (0, 0.1), representing the null hypothesis of no treatment effect. Between-study heterogeneity was elicited with a weakly informative half-Cauchy prior of a 0.5 scale. All analyses were conducted using R version 4.0.</p><p><strong>Results: </strong>9 studies met the inclusion criteria with a total of 3567 patients (1805 in fasting and 1762 in non-fasting). The Bayesian meta-analysis yielded a posterior mean OR of 0.99 [95 % credible interval (CrI): 0.82-1.20] for nausea and vomiting, 0.99 (95 % CrI: 0.82-1.21) for aspiration event, 1.003 (95 % CrI: 0.83-1.22) for new ventilation and oxygen requirements, 1.04 (95 % CrI: 0.87-1.25) for hypotension, 1.02 (95 % CrI: 0.85-1.24) for hypoglycemia, and 0.97 (95 % CrI: 0.81-1.18) for acute kidney injury. All CrI include 1 and the point estimates are very close to 1, indicating a lack of evidence to drive away from the prior assumption of no average effect size. Sensitivity analyses using three distinct prior scenarios (non-informative, optimistic informative, and skeptical informative) and a subset of studies conducted in 2023-2024 yielded similar findings.</p><p><strong>Conclusion: </strong>Our study demonstrates that a non-fasting strategy prior to cardiac catheterization is as safe as the usual fasting strategy. Pre-procedural fasting should be individualized based on patient and procedure-related factors, and guidelines should be updated with regard to pre-cardiac procedure protocols that minimize fasting and improve patient satisfaction.</p>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.carrev.2025.08.019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Fasting prior to cardiac catheterization is a routine practice to minimize the risk of complications. Recent studies suggest that non-fasting protocols may be equally safe and increase patient satisfaction. We performed a meta-analysis of randomized controlled trials (RCTs) to examine the safety of fasting versus non-fasting prior to cardiac catheterization.

Methods: We searched for eligible RCTs comparing fasting versus non-fasting protocols prior to cardiac catheterization from inception through December 21, 2024. Studies were included if they reported at least one of the outcomes of interest- nausea/vomiting, aspiration event, new ventilation/oxygen requirements, hypotension, hypoglycemia, and acute kidney injury. The treatment effect of each outcome was measured using the logarithmic odds ratios (logOR) and estimated under the Bayesian paradigm. Under the hierarchical Bayesian random effect model, we elicited an informative prior for the logOR ∼ (0, 0.1), representing the null hypothesis of no treatment effect. Between-study heterogeneity was elicited with a weakly informative half-Cauchy prior of a 0.5 scale. All analyses were conducted using R version 4.0.

Results: 9 studies met the inclusion criteria with a total of 3567 patients (1805 in fasting and 1762 in non-fasting). The Bayesian meta-analysis yielded a posterior mean OR of 0.99 [95 % credible interval (CrI): 0.82-1.20] for nausea and vomiting, 0.99 (95 % CrI: 0.82-1.21) for aspiration event, 1.003 (95 % CrI: 0.83-1.22) for new ventilation and oxygen requirements, 1.04 (95 % CrI: 0.87-1.25) for hypotension, 1.02 (95 % CrI: 0.85-1.24) for hypoglycemia, and 0.97 (95 % CrI: 0.81-1.18) for acute kidney injury. All CrI include 1 and the point estimates are very close to 1, indicating a lack of evidence to drive away from the prior assumption of no average effect size. Sensitivity analyses using three distinct prior scenarios (non-informative, optimistic informative, and skeptical informative) and a subset of studies conducted in 2023-2024 yielded similar findings.

Conclusion: Our study demonstrates that a non-fasting strategy prior to cardiac catheterization is as safe as the usual fasting strategy. Pre-procedural fasting should be individualized based on patient and procedure-related factors, and guidelines should be updated with regard to pre-cardiac procedure protocols that minimize fasting and improve patient satisfaction.

心导管插入术前禁食与非禁食方案的安全性——随机临床试验的贝叶斯荟萃分析
背景:心导管插入术前禁食是一种常规做法,以尽量减少并发症的风险。最近的研究表明,非禁食方案可能同样安全,并提高患者满意度。我们进行了一项随机对照试验(rct)的荟萃分析,以检查心导管插入术前禁食与非禁食的安全性。方法:从开始到2024年12月21日,我们检索了比较心导管插管前禁食与非禁食方案的符合条件的rct。如果研究报告了至少一项感兴趣的结果——恶心/呕吐、误吸事件、新的通气/氧气需求、低血压、低血糖和急性肾损伤,则纳入研究。使用对数优势比(logOR)测量每个结果的治疗效果,并在贝叶斯范式下进行估计。在分层贝叶斯随机效应模型下,我们得到了logOR ~(0,0.1)的信息先验,表示没有治疗效果的原假设。研究间异质性是由一个半柯西0.5级的弱信息性先验引起的。所有分析均使用R 4.0版本进行。结果:9项研究符合纳入标准,共3567例患者(禁食组1805例,非禁食组1762例)。贝叶斯meta分析得出,恶心和呕吐的后验平均OR为0.99[95%可信区间(CrI): 0.82-1.20],误吸事件的后验平均OR为0.99 (95% CrI: 0.82-1.21),新通气和需氧量的后验平均OR为1.003 (95% CrI: 0.83-1.22),低血压的后验平均OR为1.04 (95% CrI: 0.87-1.25),低血糖的后验平均OR为1.02 (95% CrI: 0.85-1.24),急性肾损伤的后验平均OR为0.97 (95% CrI: 0.81-1.18)。所有的CrI都包含1,并且点估计值非常接近1,这表明缺乏证据来推翻先前没有平均效应大小的假设。使用三种不同的先前情景(非信息性、乐观信息性和怀疑信息性)和2023-2024年进行的研究子集进行敏感性分析得出了类似的结果。结论:我们的研究表明,心导管插入术前的非禁食策略与通常的禁食策略一样安全。术前禁食应根据患者和手术相关因素进行个体化治疗,并应更新有关心脏前手术方案的指南,以尽量减少禁食并提高患者满意度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiovascular Revascularization Medicine
Cardiovascular Revascularization Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.30
自引率
5.90%
发文量
687
审稿时长
36 days
期刊介绍: Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信